ALFA Finder| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 99.1 | 87.6 | 78.7 |
| Other income | 1.5 | 1.1 | 0.9 |
| Total income | 100.6 | 88.7 | 79.6 |
| Profit before exceptional items & tax | 18.9 | 16.5 | 12.0 |
| Profit before tax | 18.9 | 16.5 | 12.0 |
| Net profit | 15.0 | 12.8 | 8.8 |
| Operating margin | 18.8% | 18.6% | 15.1% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +70.50% |
|---|---|
| Net profit, quarter on quarter | +17.20% |
| Revenue, year on year | +25.90% |
| Operating profit, year on year | +56.80% |
| Operating profit, quarter on quarter | +13.00% |
BSE results filing, NSE: SURAKSHA. Figures extracted from the filing.
Suraksha Diagnostic Ltd: key numbers
- Share price
- ₹347.70
- Market cap
- ₹1,811 Cr
- Revenue (annual)
- ₹310.4 Cr
- Net profit (annual)
- ₹32.19 Cr
- P/E (TTM)
- 43.3×Sector 54.7×
- Promoter holding
- 49.10%+0.00% QoQ
- FII holding
- 13.98%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Suraksha Diagnostic Ltd
All →Suraksha Diagnostic Earnings Call Transcript: Key Takeaways
Suraksha delivered strong high double-digit growth in Q2 FY27, crossing the ₹100 crore revenue milestone. Expansion beyond West Bengal is progressing well, though seasonal festive dips are expected in Q3.
- Call
- Guides 18% growth
Suraksha Diagnostic Investor Presentation: Key Takeaways
Q2 FY27 total income INR 1,006 Mn (+26% YoY), EBITDA INR 363 Mn (36.7% margin), PAT INR 149.5 Mn (+69%). H1 PAT INR 278 Mn (+54%). Growth driven by network expansion and maturing centres.
Suraksha Diagnostic Results Correction
Suraksha Diagnostic corrected operational metrics in its 10 November 2026 results press release. Test volumes and revenue per test were revised; financial figures are unchanged.
Suraksha Diagnostic Results Update
Suraksha Diagnostic reported H1 FY27 total income of ₹1,893.09 million and PAT of ₹277.96 million, up 54% year-on-year. The press release accompanies its unaudited quarterly results.
Suraksha Diagnostic Board Meeting Date
Suraksha Diagnostic will hold a board meeting on 10 November 2026 to consider September quarter results and other business. Trading window closes from 1 October to 12 November 2026.
Suraksha Diagnostic Other Announcement
Suraksha Diagnostic notified that RTA KFin Technologies is moving its corporate office to Kokapet, Hyderabad from 1 December 2026, with the registered office unchanged. The change is administrative and affects only the RTA's correspondence address.